Monday, September 14, 2026

Nesuparib vs. Traditional Treatments: Will This New Dual-Target Cancer Drug Change the Game for Ovarian Cancer?

Onconic Therapeutics advances Nesuparib into Phase 2 trials for ovarian cancer, aiming to validate a novel re-maintenance therapy approach.

Unlocking North Korea: How Smartphones Are Transforming Life Under Kim Jong Un

A new book explores North Korea's mobile technology, revealing how the regime uses it for control and modernization amid challenges.

Celltrion sees prescription growth for key products in Europe, raises expectations for high-margin new drugs

Celltrion's cancer and autoimmune disease treatments are achieving stable growth in Europe, expanding their market influence.

Tag: Canada-China relations

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.